Stents Drug Eluting

This channel includes news and new technology innovations for drug eluting stents (DES). These drug coated stents were developed to solve a frequent problem with bare metal stents, which can cause neointimal hyperplasia (scar tissue growth) in some patients. The antiproliferative drugs used on DES prevent the growth of tissue. One downside of DES is the requirement for patients to take long-term antiplatelet therapy to prevent the possible formation of clots on these stents. Newer generation DES use technologies help the vessels heal faster, which may allow reduce the duration of dual antiplatelet therapy (DAPT), or use a single drug, usually eliminating aspirin. This section includes news for both metallic and bioresorbable drug-eluting stents and related clinical trial data.

Biolimus Everolimus Stent Clinical Trial ACC.14
News | April 04, 2014

April 4, 2014 — A new stent covered with...

Medtronic Endeavor Stents Drug-eluting Antiplatelet Therapy Clinical Study
News | March 18, 2014

March 18, 2014 — Patients with coronary artery disease who received an Endeavor or Resolute drug-eluting stent from...

cath lab stents drug eluting boston scientific promus premier
Technology | December 02, 2013
December 2, 2013 — Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) approval for the...
Blog | November 08, 2013

By Dave Fornell, DAIC editor

The Cardiovascular Research Foundation’s Transcatheter Cardiovascular...

News | November 04, 2013
November 4, 2013 — A new study demonstrated...
Promus Element, Boston Scientific, Promus Element stent, drug-eluting stent

Boston Scientific Promus Element stent

News | November 01, 2013

November 1, 2013 – In the first head-to-head randomized controlled trial of third-generation durable-polymer...

cath lab drug-eluting balloons stents bare metal clinical trial study RIBS V
Feature | November 01, 2013
November 1, 2013 — A clinical trial...
Feature | November 01, 2013
November 1, 2013 — A study found that both...
xience prime xpedition V antiplatelet stents eluting clinical trial study cath
News | October 31, 2013
October 31, 2013 — Abbott announced it plans to initiate a randomized, controlled...
biotronik orsiro stents drug-eluting cinical trial bioflow
News | October 29, 2013
October 29, 2013 — Biotronik Japan announced enrollment of the first patient in the Bioflow-IV...
stents drug eluting biosensors tct 2012 transcatheter biomatrix neoflex spectrum
News | October 28, 2013
October 28, 2013 — Biosensors International’s expanded product portfolio offers physicians a broader range of treatment...
News | September 27, 2013

September 27, 2013 — Patient enrollment has been initiated in a post-market registry for the COMBO Dual Therapy...

Boston Scientific Concludes Evolve II Clinical Trial Enrollment Synergy Stent
News | September 17, 2013

September 17, 2013 — In a significant milestone toward obtaining additional key regulatory approvals for the Synergy...

News | August 19, 2013

August 19, 2013 — Cook Medical is again shipping its Zilver PTX drug-eluting...

News | August 16, 2013

August 16, 2013 — Patient enrollment has been initiated in a post-market registry for the Combo Dual Therapy...

Overlay Init